The findings of this study and the previous one [6] lead us to conclude that synthetic CB1 cannabinoids may elicit epigenetic changes in these cancer cells because the NF-kB pathway influences many histones and DNA methylation modifications [58,59,60,61,62]. The gene discussed is NFKB1; the disease is cancer.